Crossmark

A phase II study of surgical excision, temozolomide, radiotherapy, and anti-EGFR radioimmunotherapy (EXTRA) as adjuvant therapy in high-grade gliomas

Crossref DOI link: https://doi.org/10.1007/s13566-014-0166-3

Published Online: 2014-09-13

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Daugherty, Larry C.

Fisher, Brandon J.

Morales, Steven

Kim, Ji

Li, Linna

Quang, Tony S.

Emrich, Jacqueline

Yaeger, Theodore

Jenrette, Joseph M.

Cohen, Steven

Komarnicky, Lydia T.

Tzou, Katherine

Peterson, Jennifer

Brady, Luther W.
License Information

Text and Data Mining valid from 2014-09-13